Auryxia — Medical Mutual
Hyperphosphatemia
Initial criteria
- Patient is age ≥ 18 years
- Patient is diagnosed with Chronic Kidney Disease
- Patient is currently on dialysis
Reauthorization criteria
- Response to therapy is required for continuation of therapy
Approval duration
1 year